Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    February 2017
  1. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Text format     Abstract available


    January 2017
  2. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    PubMed     Text format     Abstract available


    October 2016
  3. VAN DEN BORN BJ, Oskam LC, Zidane M, Schachterle C, et al
    The Case| A handful of hypertension.
    Kidney Int. 2016;90:911-3.
    PubMed     Text format    


    September 2016
  4. HALLER ST, Kumarasamy S, Folt DA, Wuescher LM, et al
    Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure.
    Kidney Int. 2016 Sep 28. pii: S0085-2538(16)30443.
    PubMed     Text format     Abstract available


  5. WYATT CM, Chertow GM
    Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?
    Kidney Int. 2016;90:460-2.
    PubMed     Text format     Abstract available


    August 2016
  6. KURTZ TW, DiCarlo SE, Pravenec M, Schmidlin O, et al
    An alternative hypothesis to the widely held view that renal excretion of sodium accounts for resistance to salt-induced hypertension.
    Kidney Int. 2016 Aug 18. pii: S0085-2538(16)30310.
    PubMed     Text format     Abstract available


  7. STENGEL B
    Hypertension and glomerular function decline: the chicken or the egg?
    Kidney Int. 2016;90:254-6.
    PubMed     Text format     Abstract available


    May 2016
  8. BETZ BB, Jenks SJ, Cronshaw AD, Lamont DJ, et al
    Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Kidney Int. 2016;89:1125-35.
    PubMed     Text format     Abstract available


    April 2016
  9. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    PubMed     Text format     Abstract available


  10. ACHARYA A
    Promising biomarkers for superimposed pre-eclampsia in pregnant women with established hypertension and chronic kidney disease.
    Kidney Int. 2016;89:743-6.
    PubMed     Text format     Abstract available


    February 2016
  11. TAVASOLI M, Li L, Al-Momany A, Zhu LF, et al
    The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
    Kidney Int. 2016 Feb 24. pii: S0085-2538(16)00220.
    PubMed     Text format     Abstract available


  12. ZAIDAN M, Koumakis E, Karras A, Bruneval P, et al
    The Case | A man with hypertension, respiratory distress, and rapidly progressive renal failure.
    Kidney Int. 2016;89:509-10.
    PubMed     Text format    


  13. ROCCO MV, Cheung AK
    A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
    Kidney Int. 2016;89:261-3.
    PubMed     Text format     Abstract available


    January 2016
  14. BRAMHAM K, Seed PT, Lightstone L, Nelson-Piercy C, et al
    Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease.
    Kidney Int. 2016 Jan 19. pii: S0085-2538(15)00127.
    PubMed     Text format     Abstract available


  15. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    PubMed     Text format     Abstract available


    October 2015
  16. DENBURG MR, Jemielita TO, Tasian GE, Haynes K, et al
    Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy.
    Kidney Int. 2015 Oct 28. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    July 2015
  17. PETERS CD, Kjaergaard KD, Jensen JD, Christensen KL, et al
    The Authors Reply.
    Kidney Int. 2015;88:193-4.
    PubMed     Text format    


  18. JIMI K, Tomiyama H, Miyaoka Y, Watanabe K, et al
    Evaluating central blood pressure in dialysis patients.
    Kidney Int. 2015;88:193.
    PubMed     Text format    


    June 2015
  19. LIAO JN, Chao TF, Liu CJ, Wang KL, et al
    Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.
    Kidney Int. 2015;87:1209-15.
    PubMed     Text format     Abstract available


    May 2015
  20. REDDY MA, Natarajan R
    Recent developments in epigenetics of acute and chronic kidney diseases.
    Kidney Int. 2015 May 20. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  21. KU E, Glidden DV, Johansen KL, Sarnak M, et al
    Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.
    Kidney Int. 2015;87:1055-60.
    PubMed     Text format     Abstract available


    April 2015
  22. RUMP LC, Stegbauer J
    Coronary artery stenosis: a new risk factor for chronic kidney injury?
    Kidney Int. 2015;87:676-7.
    PubMed     Text format     Abstract available


  23. PALLET N, Mami I, Schmitt C, Karim Z, et al
    High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
    Kidney Int. 2015 Apr 1. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    February 2015
  24. DRECHSLER C, Kalim S, Wenger JB, Suntharalingam P, et al
    Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
    Kidney Int. 2015 Feb 11. doi: 10.1038/ki.2014.
    PubMed     Text format     Abstract available


    January 2015
  25. MOLITCH ME, Adler AI, Flyvbjerg A, Nelson RG, et al
    Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
    Kidney Int. 2015;87:20-30.
    PubMed     Text format     Abstract available


    November 2014
  26. LUFT FC
    The author replies:.
    Kidney Int. 2014;86:1060-1.
    PubMed     Text format    


  27. MELTZER J, Oliver J
    'SYMPLICITY: not all that simple' is, in fact, simple.
    Kidney Int. 2014;86:1060.
    PubMed     Text format    


    October 2014
  28. SARAFIDIS PA, Ruilope LM
    The authors reply.
    Kidney Int. 2014;86:855.
    PubMed     Text format    


  29. MCCORMICK BB, Hiremath S, Ruzicka M
    Lower blood pressure target in nondiabetic proteinuric chronic kidney disease is not justified.
    Kidney Int. 2014;86:855.
    PubMed     Text format    


    September 2014
  30. ZOCCALI C, Mallamaci F
    Pleiotropic effects of angiotensin II blockers in hemodialysis patients: myth or reality?
    Kidney Int. 2014;86:469-71.
    PubMed     Text format     Abstract available


    March 2014
  31. PETERS CD, Kjaergaard KD, Jensen JD, Christensen KL, et al
    No significant effect of angiotensin II receptor blockade on intermediate cardiovascular end points in hemodialysis patients.
    Kidney Int. 2014 Mar 26. doi: 10.1038/ki.2014.
    PubMed     Text format     Abstract available


    February 2014
  32. MALLIPATTU SK, Salem F, Wyatt CM
    The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy.
    Kidney Int. 2014 Feb 26. doi: 10.1038/ki.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: